Comparison of three different dressings for partial thickness burns in children: study protocol for a randomised controlled trial

Emma Gee Kee, Roy M Kimble, Leila Cuttle, Kellie Stockton, Emma Gee Kee, Roy M Kimble, Leila Cuttle, Kellie Stockton

Abstract

Background: In the paediatric population, pain and distress associated with burn injuries during wound care procedures remain a constant challenge. Although silver dressings are the gold standard for burn care in Australasia, very few high-level trials have been conducted that compare silver dressings to determine which will provide the best level of care clinically. Therefore, for paediatric patients in particular, identifying silver dressings that are associated with lower levels of pain and rapid wound re-epithelialisation is imperative. This study will determine whether there is a difference in time to re-epithelialisation and pain and distress experienced during wound care procedures among Acticoat™, Acticoat™ combined with Mepitel™ and Mepilex Ag™ dressings for acute, paediatric partial thickness burns.

Methods/design: Children aged 0 to 15 years with an acute partial thickness (superficial partial to deep partial thickness inclusive) burn injury and a burn total body surface area of ≤ 10% will be eligible for the trial. Patients will be randomised to one of the three dressing groups: (1) Acticoat™ or (2) Acticoat™ combined with Mepitel™ or (3) Mepilex Ag™. A minimum of 28 participants will be recruited for each treatment group. Primary measures of pain, distress and healing will be repeated at each dressing change until complete wound re-epithelialisation occurs or skin grafting is required. Additional data collected will include infection status at each dressing change, physical function, scar outcome and scar management requirements, cost effectiveness of each dressing and staff perspectives of the dressings.

Discussion: The results of this study will determine the effects of three commonly used silver and silicone burn dressing combinations on the rate of wound re-epithelialisation and pain experienced during dressing procedures in acute, paediatric partial thickness burn injuries.

Trial registration: Australian New Zealand Clinical Trials Registry ACTRN12613000105741.

Figures

Figure 1
Figure 1
Data collection flowchart. The chronological timing and order of data collection within the burn wound care procedure framework.

References

    1. Martin G, Swannell S, Mill J, Mott J, Evans J, Frederiksen N, Hilder M, Kimble R. Spray on skin improves psychosocial functioning in pediatric burns patients: a randomized controlled trial. Burns. 2008;34(4):498–504. doi: 10.1016/j.burns.2007.08.004.
    1. Van Baar ME, Polinder S, Essink-Bot ML, Van Loey NE, Oen IM, Dokter J, Boxma H, Van Beeck EF. Quality of life after burns in childhood (5–15 years): children experience substantial problems. Burns. 2011;37(6):930–938. doi: 10.1016/j.burns.2011.05.004.
    1. Cubison TC, Pape SA, Parkhouse N. Evidence for the link between healing time and the development of hypertrophic scars (HTS) in paediatric burns due to scald injury. Burns. 2006;32(8):992–999. doi: 10.1016/j.burns.2006.02.007.
    1. Robert R, Meyer W, Bishop S, Rosenberg L, Murphy L, Blakeney P. Disfiguring burn scars and adolescent self-esteem. Burns. 1999;25(7):581–585. doi: 10.1016/S0305-4179(99)00065-0.
    1. Gravante G, Caruso R, Sorge R, Nicoli F, Gentile P, Cervelli V. Nanocrystalline silver: a systematic review of randomized trials conducted on burned patients and an evidence-based assessment of potential advantages over older silver formulations. Ann Plast Surg. 2009;63(2):201–205. doi: 10.1097/SAP.0b013e3181893825.
    1. Miller K, Rodger S, Kipping B, Kimble RM. A novel technology approach to pain management in children with burns: a prospective randomized controlled trial. Burns. 2011;37(3):395–405. doi: 10.1016/j.burns.2010.12.008.
    1. Walburn J, Vedhara K, Hankins M, Rixon L, Weinman J. Psychological stress and wound healing in humans: a systematic review and meta-analysis. J Psychosom Res. 2009;67(3):253–271. doi: 10.1016/j.jpsychores.2009.04.002.
    1. Aziz Z, Abu SF, Chong NJ. A systematic review of silver-containing dressings and topical silver agents (used with dressings) for burn wounds. Burns. 2012;38(3):307–318. doi: 10.1016/j.burns.2011.09.020.
    1. Cavanagh MH, Burrell RE, Nadworny PL. Evaluating antimicrobial efficacy of new commercially available silver dressings. Int Wound J. 2010;7(5):394–405. doi: 10.1111/j.1742-481X.2010.00705.x.
    1. Brown AP, Khan K, Sinclair S. Bacterial toxicosis/toxic shock syndrome as a contributor to morbidity in children with burn injuries. Burns. 2003;29(7):733–738. doi: 10.1016/S0305-4179(03)00047-0.
    1. Fraser JF, Cuttle L, Kempf M, Kimble RM. Cytotoxicity of topical antimicrobial agents used in burn wounds in Australasia. A N Z J Surg. 2004;74(3):139–142. doi: 10.1046/j.1445-2197.2004.02916.x.
    1. Kempf M, Kimble RM, Cuttle L. Cytotoxicity testing of burn wound dressings, ointments and creams: a method using polycarbonate cell culture inserts on a cell culture system. Burns. 2011;37(6):994–1000. doi: 10.1016/j.burns.2011.03.017.
    1. Cuttle L, Naidu S, Mill J, Hoskins W, Das K, Kimble RM. A retrospective cohort study of Acticoat versus Silvazine in a paediatric population. Burns. 2007;33(6):701–707. doi: 10.1016/j.burns.2007.02.012.
    1. Barrett S. Mepilex® Ag: an antimicrobial, absorbent foam dressing with Safetac® technology. Br J Nurs. 2009;18(20 Suppl):S28–S36.
    1. Wasiak J, Cleland H, Campbell F. Dressings for superficial and partial thickness burns (Review) Cochrane Database Syst Rev. 2008;2008(4):1–85.
    1. Kumar RJ, Kimble RM, Boots R, Pegg SP. Treatment of partial-thickness burns: a prospective, randomized trial using Transcyte™ . A N Z J Surg. 2004;74(8):622–626. doi: 10.1111/j.1445-1433.2004.03106.x.
    1. Schulz K, Altman D, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials. 2010;11(1):32. doi: 10.1186/1745-6215-11-32.
    1. White MC, Thornton K, Young AE. Early diagnosis and treatment of toxic shock syndrome in paediatric burns. Burns. 2005;31(2):193–197. doi: 10.1016/j.burns.2004.09.017.
    1. Wang XQ, Mill J, Kravchuk O, Kimble RM. Ultrasound assessed thickness of burn scars in association with laser Doppler imaging determined depth of burns in paediatric patients. Burns. 2010;36(8):1254–1262. doi: 10.1016/j.burns.2010.05.018.
    1. Brown NJ, Rodger S, Ware RS, Kimble RM, Cuttle L. Efficacy of a children’s procedural preparation and distraction device on healing in acute burn wound care procedures: study protocol for a randomized controlled trial. Trials. 2012;13:238. doi: 10.1186/1745-6215-13-238.
    1. Hicks CL, Von Baeyer CL, Spafford PA, Van Korlaar I, Goodenough B. The faces pain scale–revised: toward a common metric in pediatric pain measurement. Pain. 2001;93(2):173–183. doi: 10.1016/S0304-3959(01)00314-1.
    1. Wilson GAM, Doyle E. Validation of three paediatric pain scores for use by parents. Anaesthesia. 1996;51(11):1005–1007. doi: 10.1111/j.1365-2044.1996.tb14991.x.
    1. Merkel S, Voepel-Lewis T, Malviya S. Pain assessment in infants and young children: the FLACC scale. Am J Nurs. 2002;102(10):55–58. doi: 10.1097/00000446-200210000-00024.
    1. Chrousos GP. Stressors, stress and neuroendocrine integration of the adaptive response: the, 1997 Hans Selye memorial lecture. Ann N Y Acad Sci. 1998;851:311–335. doi: 10.1111/j.1749-6632.1998.tb09006.x.
    1. Chambers CT, Giesbrecht K, Craig KD, Bennett SM, Huntsman E. A comparison of faces scales for the measurement of pediatric pain: children’s and parents’ ratings. Pain. 1999;83(1):25–35. doi: 10.1016/S0304-3959(99)00086-X.
    1. Silverstein P, Heimbach D, Meites H, Latenser B, Mozingo D, Mullins F, Garner W, Turkowski J, Shupp J, Glat P. et open, parallel, randomized, comparative, multicenter study to evaluate the cost-effectiveness, performance, tolerance, and safety of a silver-containing soft silicone foam dressing (intervention) vs silver sulfadiazine cream. J Burn Care Res. 2011;32(6):617–626. doi: 10.1097/BCR.0b013e318236fe31.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する